Effectiveness of afatinib after ineffectiveness of gefitinib in an advanced lung adenocarcinoma patient with a single EGFR exon 20 S768I mutation: a case report

Effectiveness of afatinib after ineffectiveness of gefitinib in an advanced lung adenocarcinoma patient with a single EGFR exon 20 S768I mutation: a case report

Hua Duan,1 Yanmei Peng,1 Huijuan Cui,2 Yuqin Qiu,1 Qiang Li,1 Jingyi Zhang,1 Wen Shen,1 Chenyao Sun,1 Chufan Luo1 1Department of China–Japan Friendship Hospital, Beijing University of Chinese Medicine, Beijing, China; 2Department of Oncology, China–Japan Friendship Hospital, Cha...

Full description

Bibliographic Details
Main Authors: Duan H, Peng Y, Cui H, Qiu Y, Li Q, Zhang J, Shen W, Sun C, Luo C
Format: Article
Language:English
Published: Dove Medical Press 2018-04-01
Series:OncoTargets and Therapy
Subjects:
NSCLC
epidermal growth factor receptor tyrosine kinase inhibitors
S768I
afatinib
gefitinib
Online Access:https://www.dovepress.com/effectiveness-of-afatinib-after-ineffectiveness-of-gefitinib-in-an-adv-peer-reviewed-article-OTT

Internet

https://www.dovepress.com/effectiveness-of-afatinib-after-ineffectiveness-of-gefitinib-in-an-adv-peer-reviewed-article-OTT

Similar Items